T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Ecolab
ECL
$78.1B
| $339M | 0.04% |
1,292,745
-891,081
| -41% | -$237M |
|
327
GoDaddy
GDDY
$11.6B
| $339M | 0.04% |
2,733,028
+235,981
| +9% | +$30.5M |
|
328
Keurig Dr Pepper
KDP
$40.2B
| $338M | 0.04% |
12,049,426
+2,845,034
| +31% | +$78.1M |
|
329
Ascendis Pharma A/S
ASND
$16.8B
| $335M | 0.04% |
1,570,260
-155,968
| -9% | -$32.2M |
|
330
Marathon Petroleum
MPC
$97.8B
| $335M | 0.04% |
2,058,676
-1,109,013
| -35% | -$207M |
|
331
FirstEnergy
FE
$27.2B
| $334M | 0.04% |
7,456,509
-125,806
| -2% | -$5.78M |
|
332
Crown Castle
CCI
$31.5B
| $332M | 0.04% |
3,732,645
-751,205
| -17% | -$69.1M |
|
|
CON
333
Concentra Group Holdings
CON
$4.4B
| $331M | 0.04% |
16,843,370
-323,383
| -2% | -$6.47M |
|
334
MACOM Technology Solutions
MTSI
$23.7B
| $331M | 0.04% |
1,934,684
+136,262
| +8% | +$21.6M |
|
|
CWAN
335
DELISTED
Clearwater Analytics
CWAN
| $331M | 0.04% |
13,715,837
+1,459,150
| +12% | +$29.2M |
|
336
Webster Financial
WBS
$12.8B
| $330M | 0.04% |
5,246,364
+713,294
| +16% | +$42.4M |
|
337
Fortinet
FTNT
$118B
| $330M | 0.04% |
4,152,703
-2,060,109
| -33% | -$171M |
|
338
Uber
UBER
$154B
| $328M | 0.04% |
4,014,008
+233,317
| +6% | +$21M |
|
339
StepStone Group
STEP
$3.96B
| $327M | 0.04% |
5,102,666
+724,201
| +17% | +$45.8M |
|
340
Dover
DOV
$28B
| $324M | 0.04% |
1,661,935
+18,863
| +1% | +$3.44M |
|
341
Cognizant
CTSH
$26.2B
| $323M | 0.03% |
3,887,737
+607,068
| +19% | +$45.4M |
|
342
Newmont
NEM
$124B
| $321M | 0.03% |
3,211,476
-3,777,721
| -54% | -$341M |
|
343
Seagate
STX
$199B
| $320M | 0.03% |
1,163,201
+319,601
| +38% | +$83M |
|
344
Roblox
RBLX
$25.4B
| $316M | 0.03% |
3,896,778
-2,002,079
| -34% | -$213M |
|
345
US Foods
USFD
$24B
| $314M | 0.03% |
4,165,611
+3,353,396
| +413% | +$252M |
|
346
Tyson Foods
TSN
$19.6B
| $312M | 0.03% |
5,317,378
+215,655
| +4% | +$11.8M |
|
347
Modine Manufacturing
MOD
$10.6B
| $312M | 0.03% |
2,333,174
+560,131
| +32% | +$83.4M |
|
348
Pfizer
PFE
$150B
| $311M | 0.03% |
12,474,452
+430,918
| +4% | +$10.9M |
|
349
CubeSmart
CUBE
$9.28B
| $308M | 0.03% |
8,543,133
-447,312
| -5% | -$17M |
|
350
3M
MMM
$94.8B
| $308M | 0.03% |
1,923,405
+670,018
| +53% | +$110M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.